Disease-specific QoL, by diabetes status
diabetes
DIABETES
Mean (SD) baseline KCCQ-12 OSS scores were similar across treatment arms and diabetes status subgroups (diabetes: 38.3 [20.5] FCM, 37.5 [19.3] placebo; no diabetes: 37.9 [19.4] FCM, 36.9 [18.6] placebo), as were baseline KCCQ-12 CSS scores (diabetes: 40.8 [21.7] FCM, 40.6 [20.2] placebo; no diabetes: 41.0 [20.0] FCM, 39.7 [20.0] placebo). Figure KCCQ-12 OSS and CSS with FCM vs placebo in patients with and without diabetes. KCCQ-12 OSS (